Cargando…
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo
The E. coli dihydrofolate reductase (DHFR) destabilizing domain (DD), which shows promise as a biologic tool and potential gene therapy approach, can be utilized to achieve spatial and temporal control of protein abundance in vivo simply by administration of its stabilizing ligand, the routinely pre...
Autores principales: | Peng, Hui, Chau, Viet Q., Phetsang, Wanida, Sebastian, Rebecca M., Stone, M. Rhia L., Datta, Shyamtanu, Renwick, Marian, Tamer, Yusuf T., Toprak, Erdal, Koh, Andrew Y., Blaskovich, Mark A.T., Hulleman, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804886/ https://www.ncbi.nlm.nih.gov/pubmed/31649953 http://dx.doi.org/10.1016/j.omtm.2019.08.002 |
Ejemplares similares
-
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging
por: Peng, Hui, et al.
Publicado: (2022) -
A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye – Implications for Ocular Gene Therapy
por: Datta, Shyamtanu, et al.
Publicado: (2018) -
Fluoroquinolone-derived fluorescent probes for studies of bacterial penetration and efflux
por: Stone, M. Rhia L., et al.
Publicado: (2019) -
Fast bacterial growth reduces antibiotic accumulation and efficacy
por: Łapińska, Urszula, et al.
Publicado: (2022) -
Protocol for Designing Small-Molecule-Regulated Destabilizing Domains for In Vitro Use
por: Ramadurgum, Prerana, et al.
Publicado: (2020)